Paloma Partners’s Vaxart VXRT Stock Holding History

Paloma Partners’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,257	Closed	-$31K	–	1446
2014 Q4	$31K	Buy	+1,257	New	+$32.2K	﹤0.01%	1110

Other funds holding VXRT

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return

Paloma Partners's VXRT Position: Q1 2015 in Review

Paloma Partners sold out of Vaxart (VXRT) in Q1 2015, closing a stake of 1,257 shares — an estimated $31K sold.

Paloma Partners first reported a position in VXRT in Q4 2014 and held it in 1 quarter. The position peaked at $31K in Q4 2014. 49 funds tracked by Wall St. Rank hold VXRT as of Q1 2015.

Paloma Partners reported no remaining Vaxart position as of Q1 2015 after selling out during the quarter.
Paloma Partners sold 1,257 Vaxart shares in Q1 2015, an estimated $31K.
Paloma Partners first reported a position in Vaxart in Q4 2014 and held it in 1 quarter.
Paloma Partners's Vaxart position peaked at $31K in Q4 2014.
49 funds tracked by Wall St. Rank held Vaxart as of Q1 2015.

Based on Paloma Partners's 13F filing for Q1 2015, filed 15 May 2015.